We subsequently produced a more distinct probe, [18F]CFA, which was Utilized in The existing analyze to evaluate dCK activity in tumors when taken care of with a small molecule dCK inhibitor. This probe is usually getting analyzed in the medical trial at our institution To judge adjustments in dCK action pursuing cancer immunotherapy 18. PET probes